LYTGOBI FDA approval date

The FDA approved LYTGOBI on 30 Sep 2022.

FDA approval date
30 Sep 2022

Drug identity has not yet been verified against registry records

Also recorded as FUTIBATINIB

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2022-09-30DayLYTGOBIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA214801", "applicant_as_listed_by_fda": "TAIHO ONCOLOGY", "brand_names": ["LYTGOBI"], "active_ingredients": ["FUTIBATINIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20220930", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026